Anika Therapeutics Inc. (ANIK)
Last updated: 2026-10-21 23:56:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Anika Therapeutics Inc. (ANIK) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $20.60, with a market capitalization of $270.60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $9.01 to $22.88. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$270.60M | |
$20.48 | |
$75.72 | |
$2.96 | |
$20.44 | |
42.53K | |
109.43K | |
-- | |
$22.88 | |
$9.01 | |
-- | |
-- |
Anika Therapeutics Inc. (ANIK) After-Hours Stock Price
Anika Therapeutics Inc. (ANIK) is trading at $20.60 in after-hours trading as of 2026-10-21 19:59:44, up 0.78% ($0.16) from the regular-session close of $20.44.
After-hours trading shows how investors are pricing ANIK after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Anika Therapeutics Inc. (ANIK) 7-Day Stock Price Change
Over the past seven days, Anika Therapeutics Inc. (ANIK) moved from $20.47 to $20.60, representing a gain of 0.63% ($0.13).
The stock traded between $19.33 and $20.91 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 134.08 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
ANIK 52-Week Price Position
Position in Range: 83.5%
ANIK is currently trading at $20.60, placing it 83.5% of the way from its 52-week low of $9.01 to its 52-week high of $22.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Anika Therapeutics Inc. (ANIK)?
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Anika Therapeutics Inc. Information
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 235 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Anika Therapeutics Inc. (ANIK) Stock on MEXC
Eligible investors can buy real shares of Anika Therapeutics Inc. (ANIK) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Anika Therapeutics Inc. (ANIK) stock price today?
2.Is ANIK stock going up or down today?
3.What is ANIK pre-market price?
4.What is ANIK after-hours price?
5.Is ANIK stock trading now?
6.Where does ANIK sit relative to its 52-week high and low?
7.What sector is Anika Therapeutics Inc. in?
8.What is Anika Therapeutics Inc.'s market capitalization and where is it listed?
9.How is ANIK valued in terms of P/E ratio and EPS?
10.Does Anika Therapeutics Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ANIK Stock Calculator
Estimate the value between ANIK shares and USD.
ANIK Shares to USD
1.00 ANIK shares = 20.598 USD
Calculations are estimates based on the latest available price and are for reference only.


